Search research articles
Contact Us
Filters
Showing results (51-60 of 192) with videos related to
Page
of 20
Sort By:
Critical Reviews in Oncogenesis
|
February 9, 2026
Review Article: EZH2 in Pancreatic Cancer: Epigenetic Driver and Therapeutic Target
Talia Festekdjian, Benjamin Bonavida
Journal of Experimental & Clinical Cancer Research : CR
|
December 2, 2025
The YYR (YY1- RKIP) Regulatory Axis in the pathogenesis of Cancer and Immune Evasion
William Ung, Benjamin Bonavida
Critical Reviews in Immunology
|
May 19, 2020
Involvement of Yin Yang 1 (YY1) Expression in T-Cell Subsets Differentiation and Their Functions: Implications in T Cell-Mediated Diseases
Feodora Roxanne Kosasih, Benjamin Bonavida
Critical Reviews in Oncogenesis
|
June 25, 2025
Review Article: Probiotics and Oncogenesis: Clinical Implications
Brayden K Leyva, Benjamin Bonavida
Molecular Cancer Therapeutics
|
January 30, 2004
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis
Ali R Jazirehi, Benjamin Bonavida
Methods in Molecular Biology (Clifton, N.J.)
|
April 26, 2011
Development of rituximab-resistant B-NHL clones: an in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy
Ali R Jazirehi, Benjamin Bonavida
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 9, 2005
Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma
Benjamin Bonavida, Mario I Vega
Oncogene
|
March 25, 2005
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention
Ali R Jazirehi, Benjamin Bonavida
Critical Reviews in Oncogenesis
|
April 2, 2018
Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis
Anne Arah Cho, Benjamin Bonavida
Molecular Cancer Therapeutics
|
December 17, 2002
X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO)
Chuen-Pei Ng, Benjamin Bonavida
Page
of 20
Search research articles
Search
Showing results (51-60 of 192) with videos related to
Sort By:
Page
of 20
Critical Reviews in Oncogenesis
|
February 9, 2026
Review Article: EZH2 in Pancreatic Cancer: Epigenetic Driver and Therapeutic Target
Talia Festekdjian, Benjamin Bonavida
Journal of Experimental & Clinical Cancer Research : CR
|
December 2, 2025
The YYR (YY1- RKIP) Regulatory Axis in the pathogenesis of Cancer and Immune Evasion
William Ung, Benjamin Bonavida
Critical Reviews in Immunology
|
May 19, 2020
Involvement of Yin Yang 1 (YY1) Expression in T-Cell Subsets Differentiation and Their Functions: Implications in T Cell-Mediated Diseases
Feodora Roxanne Kosasih, Benjamin Bonavida
Critical Reviews in Oncogenesis
|
June 25, 2025
Review Article: Probiotics and Oncogenesis: Clinical Implications
Brayden K Leyva, Benjamin Bonavida
Molecular Cancer Therapeutics
|
January 30, 2004
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis
Ali R Jazirehi, Benjamin Bonavida
Methods in Molecular Biology (Clifton, N.J.)
|
April 26, 2011
Development of rituximab-resistant B-NHL clones: an in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy
Ali R Jazirehi, Benjamin Bonavida
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 9, 2005
Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma
Benjamin Bonavida, Mario I Vega
Oncogene
|
March 25, 2005
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention
Ali R Jazirehi, Benjamin Bonavida
Critical Reviews in Oncogenesis
|
April 2, 2018
Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis
Anne Arah Cho, Benjamin Bonavida
Molecular Cancer Therapeutics
|
December 17, 2002
X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO)
Chuen-Pei Ng, Benjamin Bonavida
Page
of 20